HBSP (USA)
-
Organization and Strategy at Millennium (A)
Wulf, Julie M.; Waggoner, ScottCase HBS-710415-ELeadership and People ManagementThis case examines Millennium's strategic and organizational responses to the rapid evolution of the biopharmaceutical industry. In the early 2000s, as Millennium's competitive advantage in early-stage research slipped away and its losses mounted, founder and CEO Mark Levin moved the firm downstream away from research and towards drug development and commercialization, while narrowing horizontal breadth from over a dozen therapeutic classes to ju...Starting at €8.20
-
Organization and Strategy at Millennium (B)
Wulf, Julie M.; Waggoner, ScottCase HBS-710418-EStrategyThis case examines Millennium's strategic and organizational responses to the rapid evolution of the biopharmaceutical industry. In the early 2000s, as Millennium's competitive advantage in early-stage research slipped away and its losses mounted, founder CEO Mark Levin moved the firm downstream away from research and towards drug development and commercialization, while narrowing horizontal breadth from over a dozen therapeutic classes to just t...Starting at €5.74
-
Innovating into Active ETFs: Factor Funds Capital Management LLC
Froot, Kenneth A.; Cohen, Lauren H.; Waggoner, ScottCase HBS-211031-EFinanceKishore Karunakaran, President and COO of FFCM, faces a variety of challenges in launching an innovative investment management business in the rapidly evolving ETF space.Starting at €8.20
-
BlackRock Solutions
Froot, Kenneth A.; Waggoner, ScottCase HBS-211082-EFinanceThe BlackRock Solutions case examines the different functions and economics of a global asset manager's value chain, with particular emphasis on the "money management" and the "investment systems platform" businesses. Students analyze why BlackRock decided to unbundle its Aladdin investment platform and if the firm should consider expanding the platform in the future. Students also explore the resulting "dual-mission" challenges of servicing both...Starting at €8.20
-
TransDigm in 2017: The Beginning of the End or the End of the Beginning?
Esty, Benjamin C.; Fisher, DanielCase HBS-720422-EStrategyTransDigm was a highly acquisitive company that manufactured a wide range of highly engineered aerospace parts for both military and commercial customers. Over the ten years ending in 2016, its stock price had increase ten times, and both EBITDA and revenues had grown at compound annual rates in excess of 20%. But in early 2017, investors, customers, and government officials began to question the implementation, sustainability, and ethics of the ...Starting at €8.20
-
Gillette: Cutting Prices to Regain Share
Esty, Benjamin C.; Fisher, DanielCase HBS-720378-EStrategyAfter losing market share to low-priced competitors such as Harry's and Dollar Shave Club for several years, Gillette decided to fight back by launching new products and increasing advertising. When these efforts failed to stem the losses, Gillette decided to cut the prices on its razors and blades in April 2017. Bonnie Herzog, an equity analyst at Wells Fargo, must assess how the recently announced price cuts are likely to affect Gillette's earn...Starting at €8.20
-
Fixing Facebook: Fake News, Privacy, and Platform Governance
Yoffie, David B.; Fisher, DanielCase HBS-720400-EStrategyMark Zuckerberg founded Facebook based on the idea that connecting people was a fundamentally good thing-and a way to turn a handsome profit. But from the beginning, Facebook received criticism both for how it handled user privacy and how it curated user-generated content. These two issues coalesced in the aftermath of the 2016 United States presidential election, after Facebook's role in the spread of political misinformation and the leak of Fac...Starting at €8.20
-
Fixing Facebook: Fake News, Privacy, and Platform Governance, Teaching Note
Yoffie, David B.; Fisher, DanielTeaching Note HBS-720417-EStrategyTeaching note for case 720400.Starting at €0.00
-
Intellectual Ventures Update 2020
Yoffie, David B.; Fisher, DanielCase HBS-720438-EStrategyAfter raising $6 billion and buying 60,000 patents, Intellectual Venture was confronted with a changing legal environment. A number of important legal decision, including the Supreme Court's so-called "Alice" decision, IV had to shift strategy. IV sold off a substantial portion of its IP portfolio, and refocused its efforts on trying to innovate, using its acquired technologies.Starting at €8.20
-
MoviePass: The "Get Big Fast" Strategy
Esty, Benjamin C.; Fisher, DanielCase HBS-719455-EStrategyIn August 2017, MoviePass dramatically lowered its subscription price from $50 per month to just $10 for up to one movie per day. The idea was to rapidly scale the business to the point where it could generate incremental revenue streams from related businesses (e.g., a share of ticket and concession revenues from theaters, advertising revenue from movie studios; and revenue from ride-sharing companies). Within two days, Moviepass had gotten 150k...Starting at €8.20